Synthesis and pharmacology of N-(4-diethylamino-2-butynyl)-succinimide (DKJ 21), a new central anticholinergic agent.
D000480:Alkynes; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001337:Autonomic Agents / Q000494:pharmacology; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D002625:Chemistry, Organic; D006846:Hydrocarbons, Halogenated; D051379:Mice; D055601:Organic Chemistry Phenomena; D010276:Parasympatholytics / Q000494:pharmacology*; D011680:Pupil / Q000187:drug effects; D011760:Pyrrolidinones; D014202:Tremor / Q000139:chemically induced; D014203:Tremorine
D000480:Alkynes; D001337:Autonomic Agents; D006846:Hydrocarbons, Halogenated; D010276:Parasympatholytics; D011760:Pyrrolidinones; D001285:Atropine; D014203:Tremorine